JBJovica D. Badjić

Jovica D. Badjić

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jovica D. Badjić has a total of 166 co-authors. Here are the top co-authors by number of shared publications:

  • Tyler J. Finnegan

    Department of Chemistry and Biochemistry, The Ohio State University, 100 West 18th Avenue, Columbus, Ohio 43210, USA

    20 shared publications
  • Christopher Martin Hadad

    Department of Chemistry and Biochemistry, College of Arts and Sciences, The Ohio State University, Columbus, OH 43210, USA

    19 shared publications
  • Radoslav Z. Pavlović

    Department of Chemistry and Biochemistry The Ohio State University 100 West 18th Avenue 43210, Ohio Columbus USA

    17 shared publications
  • Han Xie

    Department of Chemistry and Biochemistry, The Ohio State University, 100 West 18th Avenue, Columbus, OH, USA

    14 shared publications
  • Lei Zhiquan

    Department of Chemistry & Biochemistry The Ohio State University 100W. 18th Avenue Columbus OH 43210 USA

    14 shared publications
  • Vageesha W. Liyana Gunawardana

    Department of Chemistry and Biochemistry The Ohio State University 100 West 18th Avenue Columbus OH 43210 USA

    12 shared publications

Latest Publications

  • Open Access

    Coupled equilibria characterizing the binding of the anticancer drug mitoxantrone to a dendritic molecular basket

    by Nitesh Kumar, Purva S. Damale, Abraham K. Badu-Tawiah, Jovica D. Badjić

    The polyanionic dendritic basket encapsulates the dicationic anticancer drug mitoxantrone within its cavity while simultaneously binding additional drug molecules on its outer surface.

  • Open Access

    Inclusion Complexations of Levamisole and Cocaine With Molecular Baskets. Fluorescence Displacement Assay for Detection of Cocaine and Its Adulterant Levamisole in Aqueous Media

    by Christopher T. Mortensen, Carson E. Ward, Nitesh Kumar, Logan Willemann, Ryan Lutz, Kailey Hughes, Zheng Zheng, Jovica D. Badjić

    We investigated inclusion complexation of levamisole (LEV + ), a common adulterant of cocaine (COC + ), with six molecular baskets 1 3− –6 18− of increasing cavity depth and anionic charge at the portal. 1 H NMR and mass spectrometry showed that 1 3− to 6 18− bind to LEV + to form binary complexes in water, with the stability increasing across the series and highest for dendritic basket 6 18− ( K d = 10 µM). From 1 H NMR magnetic shielding and OPLS4 calculations, we deduced that LEV + inserts its benzene in the binding pocket of 1 3− – 6 18− while the protonated heterocycle remains near the anionic portal. The stability of [LEV⊂ 6 ] 17− arises from C−H … π/cation … π/π−π contacts, ion pairing, and hydrophobic effect (Δ H° < 0, ITC). Dendritic basket 6 18− was subsequently used to develop a fluorescent displacement assay (FDA) for the detection of LEV + with alizarin red S (ALZ − ) as a fluorescence reporter. LEV + displaced the dye to generate a fluorescence response suitable for its detection in water over circa 10–300 µM range. In contrast, COC + bound more strongly to basket 6 18− , forming binary ( K d = 1 µM) and ternary complexes ( 1 H NMR, calorimetry, and FDA). The binding mode of COC + differs from that of LEV + , with the drug's cationic fragment occupying the basket's cavity.


  • Open Access

    Narcissistic assembly of homochiral covalent organic cages with dehydrobenzo[12]annulene (DBA) panels

    by Carson E. Ward, Ryan J. Maguire, Nitesh Kumar, Christopher M. Hadad, Jovica D. Badjić

    Trivalent dehydrobenzo[12]annulenes (DBA) are assembled into homochiral organic cages through dynamic imine condensation and narcissistic self-sorting of the constituent building blocks.

  • Open Access

    Correction: Molecular bowls for inclusion complexation of toxic anticancer drug methotrexate

    by Pratik Karmakar, Tyler J. Finnegan, Darian C. Rostam, Sagarika Taneja, Sefa Uçar, Alexandar L. Hansen, Curtis E. Moore, Christopher M. Hadad, Kornkanya Pratumyot, Jon R. Parquette, et al.

    Correction for ‘Molecular bowls for inclusion complexation of toxic anticancer drug methotrexate’ by Pratik Karmakar et al. , Chem. Sci. , 2024, 15 , 10155–10163, https://doi.org/10.1039/D3SC05627A.

  • Open Access

    Dendritic Pillar[6]Arenes with Fixed Planar Chirality for Stereoselective Inclusions in Water: A Case of Facile Differentiation of Cocaine Adulterants, Levamisole and Dexamisole

    by Nitesh Kumar, Pratik Karmakar, Matthew D. Politeski, Alexandar R. Hansen, Carson E. Ward, Christopher Mortensen, Christopher M. Hadad, Kornkanya Pratumyot, Jovica D. Badjić

    We describe the preparation, conformational dynamics, and stereoselective recognition characteristics of water‐soluble pillar[6]arenes pS–212− and pR–212−. These two novel and diastereomeric cavitands comprise a 2,5‐bis(ethoxy)pillar[6]arene core with one of six phenylene ring conjugated to two hexaanionic dendrons. Each dendron includes an (S)−glutamic acid amidated with two tris‐carboxylic Behera's amines. Cavitands pS–212− and pR–212− were obtained in six synthetic steps and resolved by column chromatography. The results of 1H NMR and circular dichroism spectroscopic measurements are in line with pS/pR–212− having unidirectional orientation of alkoxy substituents (i.e., planar chirality) and no observable interconversion for, at least, 2 weeks. Computational studies supported with 1H DOSY NMR measurements revealed that sufficiently bulky dendrons require high activation energy to pass through the pillararene's cylindrical cavity therefore inhibiting rotation of the phenylene holding them. With the unique and chiral binding pocket, pS–212− (pR–212−) formed inclusion complexes with cocaine adulterants levamisole and dexamisole (Kd > mM), with their racemic mixture showing separate 1H NMR spectroscopic resonances. In this way, dendritic pillar[6]arenes can be used as chiral shift reagents for determining enantiopurity of pharmaceuticals but also for examining a variety of chiral recognition processes, sensing of chiral molecules, and stereoselective sequestrations in aqueous media.


  • Open Access

    Dendritic Pillar[6]Arenes with Fixed Planar Chirality for Stereoselective Inclusions in Water: A Case of Facile Differentiation of Cocaine Adulterants, Levamisole and Dexamisole

    by Nitesh Kumar, Pratik Karmakar, Matthew D. Politeski, Alexandar R. Hansen, Carson E. Ward, Christopher Mortensen, Christopher M. Hadad, Kornkanya Pratumyot, Jovica D. Badjić

    We describe the preparation, conformational dynamics, and stereoselective recognition characteristics of water‐soluble pillar[6]arenes pS–212− and pR–212−. These two novel and diastereomeric cavitands comprise a 2,5‐bis(ethoxy)pillar[6]arene core with one of six phenylene ring conjugated to two hexaanionic dendrons. Each dendron includes an (S)−glutamic acid amidated with two tris‐carboxylic Behera's amines. Cavitands pS–212− and pR–212− were obtained in six synthetic steps and resolved by column chromatography. The results of 1H NMR and circular dichroism spectroscopic measurements are in line with pS/pR–212− having unidirectional orientation of alkoxy substituents (i.e., planar chirality) and no observable interconversion for, at least, 2 weeks. Computational studies supported with 1H DOSY NMR measurements revealed that sufficiently bulky dendrons require high activation energy to pass through the pillararene's cylindrical cavity therefore inhibiting rotation of the phenylene holding them. With the unique and chiral binding pocket, pS–212− (pR–212−) formed inclusion complexes with cocaine adulterants levamisole and dexamisole (Kd > mM), with their racemic mixture showing separate 1H NMR spectroscopic resonances. In this way, dendritic pillar[6]arenes can be used as chiral shift reagents for determining enantiopurity of pharmaceuticals but also for examining a variety of chiral recognition processes, sensing of chiral molecules, and stereoselective sequestrations in aqueous media.


  • Open Access

    O-GlcNAc transferase plays dual antiviral roles by integrating innate immunity and lipid metabolism

    by Hong Dong, Chenxi Liang, Junjie Zhang, Weidong Wu, Nitesh Kumar, Zihao Liu, Yajun Sun, Zhiwei Liao, Xiaolin Cheng, Yanbao Yu, et al.

    Viral infection induces robust reprogramming of metabolic pathways in host cells. However, whether host metabolic enzymes detect viral components remains unknown. Our group and others previously identified O-GlcNAc transferase (OGT), an important glucose metabolic enzyme, as a crucial mediator of the antiviral immune responses. Here, by studying a mouse model with a catalytically impaired OGT, we discover a catalytic activity-independent function of OGT in restraining influenza A virus (IAV) infection in addition to its catalytic activity-dependent effect on MAVS-mediated antiviral immunity. Biochemical studies reveal a critical antiviral effect based on OGT interacting with IAV genomic RNA that requires its N-terminal tetracopeptide repeat-4 motif. This interaction causes the translocation of nuclear OGT to cytosolic lipid droplets (LDs) to destabilize LDs-coating perilipin 2, thereby limiting LDs accumulation and in turn virus replication. In sum, our findings reveal OGT as a multifaceted metabolic sensor that integrates MAVS signaling and lipid metabolism to combat viral infection.


  • Open Access

    Dendritic Molecular Baskets for Selective Binding of Toxic Methotrexate

    by Nitesh Kumar, Tyler J. Finnegan, Sagarika Taneja, Darian C. Rostam, Alexandar L. Hansen, Carson E. Ward, Sefa Uçar, Jon R. Parquette, Jovica D. Badjić

    We describe the preparation, assembly, recognition characteristics, and bioactivity of dendritic basket 612−. This novel cavitand has a deep aromatic pocket with three (S)‐glutamic acid dendrons at the rim to amplify water solubility and prevent self‐association. 1H NMR spectroscopy, calorimetry (ITC), and mass spectrometry (ESI‐MS) measurements validate the formation of an inclusion complex between 612− and anticancer drug methotrexate (MTX2−) in water (Kd=9.2 μM). To identify the docking pose, a comparison of computed (DFT and MM) and experimental 1H NMR chemical shifts suggests that MTX2− folds inside 612− (π⋅⋅⋅π), forming HBs with the peptidic dendrons while anchoring (C−H⋅⋅⋅π) to the aromatic pocket through its N‐methyl group. In consequence, 612− selectively binds MTX2− in competition with structurally similar folic acid and leucovorin (reversal poisoning agent). While the host is biocompatible (HEK293; IC50>150 μM) and produces inclusion complex [MTX⊂6]14− in cell media, it experiences limitation in pharmacokinetic sequestration of MTX2− as dihydrofolate reductase's affinity to the drug is suggested to prevail over that of 612−. Nonetheless, considering the basket's biocompatibility, tunability, and chemoselectivity, it stands as the leading candidate in the pursuit of an effective abiotic antidote for methotrexate poisoning.


  • Open Access

    Dendritic Molecular Baskets for Selective Binding of Toxic Methotrexate

    by Nitesh Kumar, Tyler J. Finnegan, Sagarika Taneja, Darian C. Rostam, Alexandar L. Hansen, Carson E. Ward, Sefa Uçar, Jon R. Parquette, Jovica D. Badjić

    We describe the preparation, assembly, recognition characteristics, and bioactivity of dendritic basket 612−. This novel cavitand has a deep aromatic pocket with three (S)‐glutamic acid dendrons at the rim to amplify water solubility and prevent self‐association. 1H NMR spectroscopy, calorimetry (ITC), and mass spectrometry (ESI‐MS) measurements validate the formation of an inclusion complex between 612− and anticancer drug methotrexate (MTX2−) in water (Kd=9.2 μM). To identify the docking pose, a comparison of computed (DFT and MM) and experimental 1H NMR chemical shifts suggests that MTX2− folds inside 612− (π⋅⋅⋅π), forming HBs with the peptidic dendrons while anchoring (C−H⋅⋅⋅π) to the aromatic pocket through its N‐methyl group. In consequence, 612− selectively binds MTX2− in competition with structurally similar folic acid and leucovorin (reversal poisoning agent). While the host is biocompatible (HEK293; IC50>150 μM) and produces inclusion complex [MTX⊂6]14− in cell media, it experiences limitation in pharmacokinetic sequestration of MTX2− as dihydrofolate reductase's affinity to the drug is suggested to prevail over that of 612−. Nonetheless, considering the basket's biocompatibility, tunability, and chemoselectivity, it stands as the leading candidate in the pursuit of an effective abiotic antidote for methotrexate poisoning.


  • Open Access

    Molecular bowls for inclusion complexation of toxic anticancer drug methotrexate

    by Pratik Karmakar, Tyler J. Finnegan, Darian C. Rostam, Sagarika Taneja, Sefa Uçar, Alexandar L. Hansen, Curtis E. Moore, Christopher M. Hadad, Kornkanya Pratumyot, Jon R. Parquette, et al.

    We describe the preparation and study of novel cavitands, molecular bowls 16+ and 26+, as good binders of the anticancer drug methotrexate (MTX). Molecular bowls are comprised of a curved tribenzotriquinacene (TBTQ) core conjugated to three macrocyclic pyridinium units at the top. The cavitands are easily accessible via two synthetic steps from hexabromo-tribenzotriquinacene in 25% yield. As amphiphilic molecules, bowls 16+ and 26+ self-associate in water by the nucleation-to-aggregation pathway (NMR). The bowls are preorganized, having a semi-rigid framework comprising a fixed bottom with a wobbling pyridinium rim (VT NMR and MD). Further studies, both experimental (NMR) and computational (DFT and MCMM), suggested that a folded MTX occupies the cavity of bowls wherein it forms π–π, C–H–π, and ion pairing intermolecular contacts but also undergoes desolvation to give stable binary complexes (μM) in water. Moreover, a computational protocol is introduced to identify docking pose(s) of MTX inside molecular bowls from NMR shielding data. Both molecular bowls have shown in vitro biocompatibility with liver and kidney cell lines (MTS assay). As bowl 26+ is the strongest binder of MTX reported to date, we envision it as an excellent candidate for further studies on the way toward developing an antidote capable of removing MTX from overdosed cancer patients.